Assessment of subclinical diabetic cardiomyopathy by speckle-tracking imaging.
diabetic cardiomyopathy
diastolic dysfunction
speckle-tracking echocardiography
strain
subclinical
systolic dysfunction
Journal
European journal of clinical investigation
ISSN: 1365-2362
Titre abrégé: Eur J Clin Invest
Pays: England
ID NLM: 0245331
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
17
10
2020
revised:
28
11
2020
accepted:
05
12
2020
pubmed:
17
12
2020
medline:
30
11
2021
entrez:
16
12
2020
Statut:
ppublish
Résumé
Diastolic dysfunction is traditionally believed to be the first subclinical manifestation of diabetic cardiomyopathy (DCM), leading to systolic dysfunction and then overt heart failure. However, in the last few years, several studies suggested that systolic subclinical dysfunction measured by speckle-tracking echocardiography (STE) may appear ahead of diastolic dysfunction. In this review, the main endpoint is to show whether subclinical myocardial systolic dysfunction appears ahead of diastolic dysfunction and the implication this may have on the evolution and management of DCM. We performed a search in PubMed for all relevant publications on the assessment of DCM by STE from 1 June 2015 to 1 June 2020. The results illustrate that subclinical systolic dysfunction assessed by STE is present in early DCM stages, with or without the association of diastolic dysfunction. This could be a promising perspective for the early management of patients with DCM leading to the prevention of the overt form of disease.
Sections du résumé
BACKGROUND
BACKGROUND
Diastolic dysfunction is traditionally believed to be the first subclinical manifestation of diabetic cardiomyopathy (DCM), leading to systolic dysfunction and then overt heart failure. However, in the last few years, several studies suggested that systolic subclinical dysfunction measured by speckle-tracking echocardiography (STE) may appear ahead of diastolic dysfunction. In this review, the main endpoint is to show whether subclinical myocardial systolic dysfunction appears ahead of diastolic dysfunction and the implication this may have on the evolution and management of DCM.
MATERIALS AND METHODS
METHODS
We performed a search in PubMed for all relevant publications on the assessment of DCM by STE from 1 June 2015 to 1 June 2020.
RESULTS AND CONCLUSIONS
CONCLUSIONS
The results illustrate that subclinical systolic dysfunction assessed by STE is present in early DCM stages, with or without the association of diastolic dysfunction. This could be a promising perspective for the early management of patients with DCM leading to the prevention of the overt form of disease.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13475Informations de copyright
© 2020 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
Références
Lorenzo-Almorós A, Tuñón J, Orejas M, et al. Diagnostic approaches for diabetic cardiomyopathy. Cardiovasc Diabetol. 2017;16:1-14.
Negishi K. Echocardiographic feature of diabetic cardiomyopathy: where are we now? Cardiovasc Diagn Ther. 2018;8:47-56.
Mochizuki Y, Tanaka H, Matsumoto K, et al. Impact of left ventricular longitudinal functional mechanics on the progression of diastolic function in diabetes mellitus. Int J Cardiovasc Imaging. 2017;33:1905-1914.
Loncarevic B, Trifunovic D, Soldatovic I, et al. Silent diabetic cardiomyopathy in everyday practice: A clinical and echocardiographic study. BMC Cardiovasc Disord. 2016;16:1-11.
Tadic M, Cuspidi C, Vukomanovic V, et al. Déformation myocardique ventriculaire gauche chez les diabétiques de type II hypertendus. Arch Cardiovasc Dis. 2018;111:17-24.
Natali A, Nesti L, Fabiani I, et al. Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: Rationale and design of the EMPA-HEART trial. Cardiovasc Diabetol. 2017;16:1-12.
Ringle A, Dornhorst A, Rehman MB, et al. Evolution of subclinical myocardial dysfunction detected by two-dimensional and three-dimensional speckle tracking in asymptomatic type 1 diabetic patients: a long-term follow-up study. Echo Res Pract. 2017;4:73-81.
Jȩdrzejewska I, Król W, Światowiec A, et al. Left and right ventricular systolic function impairment in type 1 diabetic young adults assessed by 2D speckle tracking echocardiography. Eur Heart J Cardiovasc Imaging. 2016;17:438-446.
Costantino S, Paneni F, Mitchell K, et al. Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66Shc. Int J Cardiol. 2018;268:179-186.
Liu X-Y, Liu F-C, Deng C-Y, et al. Left ventricular deformation associated with cardiomyocyte Ca2+ transients delay in early stage of low-dose of STZ and high-fat diet induced type 2 diabetic rats. BMC Cardiovasc Disord. 2016;16:41.
Mátyás C, Kovács A, Németh BT, et al. Comparison of speckle-tracking echocardiography with invasive hemodynamics for the detection of characteristic cardiac dysfunction in type-1 and type-2 diabetic rat models. Cardiovasc Diabetol. 2018;17:1-13.
Mondillo S, Galderisi M, Mele D, et al. Speckle-Tracking Echocardiography - A new technique for assessing myocardial function. J Ultrasound Med. 2011;30:71-83.
Lancellotti P, Zamorano JL, Habib G, et al. Deformation echocardiography. In: Cameli M, Sengupta P, Edvardsen T, eds. The EACVI Textbook of Echocardiography, 2nd edn. Oxford: Oxford University Press; 2017:35-41.
Ernande L, Audureau E, Jellis CL, et al. Clinical implications of echocardiographic phenotypes of patients with diabetes mellitus. J Am Coll Cardiol. 2017;70:1704-1716.
Zhou Y, Xiao H, Wu J, et al. Type I diabetic akita mouse model is characterized by abnormal cardiac deformation during early stages of diabetic cardiomyopathy with speckle-tracking based strain imaging. Cell Physiol Biochem. 2018;45:1541-1550.
Aboukhoudir F, Aboukhoudir I, Rekik S. Échocardiographie À La Dobutamine Ou Étude De La Déformation Longitudinale Au Repos Pour Démasquer Une Cardiomyopathie Diabétique Débutante Symptomatique ? Ann Cardiol Angeiol. 2017;66:330-334.
Derumeaux GA. From metabolic exposome to onset of diabetic cardiomyopathy. JACC Cardiovasc Imaging. 2017;10:115-117.
Leung M, Wong VW, Hudson M, et al. Impact of improved glycemic control on cardiac function in type 2 diabetes mellitus. Circ Cardiovasc Imaging. 2016;9:1-10.
Bonapace S, Valbusa F, Bertolini L, et al. Early impairment in left ventricular longitudinal systolic function is associated with an increased risk of incident atrial fibrillation in patients with type 2 diabetes. J Diabetes Complications. 2017;31:413-418.
Theilade S, Rossing P, Jensen JS, et al. Arterial-ventricular coupling in type 1 diabetes: arterial stiffness is associated with impaired global longitudinal strain in type 1 diabetes patients-the Thousand & 1 Study. Acta Diabetol. 2018;55:21-29.
Stevanovic A, Dekleva M. The importance of subclinical left ventricular dysfunction and blood pressure pattern in asymptomatic type-2 diabetic patients: the diagnostic and prognostic significance of Tissue Doppler parameters, left ventricular global longitudinal strain, and night. J Diabetes Complications. 2018;32:41-47.
Tabako S, Harada M, Sugiyama K, et al. Association of Left Ventricular Myocardial Dysfunction With Diabetic Polyneuropathy. J Med Ultrason. 2019;46(1):69-79.
Athithan L, Gulsin GS, McCann GP, et al. Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date. World J Diabetes. 2019;10(10):490-510.
Pappritz K, Grune J, Klein O, et al. Speckle-tracking echocardiography combined with imaging mass spectrometry assesses region-dependent alterations. Sci Rep. 2020;10(1):3629.
Chen X, Guo H, Yang Q, et al. Quantitative EVALUATION OF SUBCLINICAL LEFT VENTRICULAR DYSFUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY THREE-DIMENSIONAL ECHOCARDIography. Int J Cardiovasc Imaging. 2020;36(7):1311-1319.
Enomoto M, Ishizu T, Seo Y, et al. Myocardial dysfunction identified by three-dimensional speckle tracking echocardiography in type 2 diabetes patients relates to complications of microangiopathy. J Cardiol. 2016;68:282-287.
Tadic M, Vukomanovic V, Cuspidi C, et al. The relationship between right ventricular deformation and heart rate variability in asymptomatic diabetic patients. J Diabetes Complications. 2017;31:1152-1157.
Qiao Y-Y, Zeng M, Li R-J, et al. Layer-specific myocardial strain analysis: investigation of regional deformation in a rabbit model of diabetes mellitus during different stages. Med Ultrason. 2016;18:339-344.
Bogdanović J, Milika Ašanin M, Krljanac G, et al. Impact of acute hyperglycemia on layer-specific left ventricular strain in asymptomatic diabetic patients: an analysis based on two-dimensional speckle tracking echocardiography. Cardiovasc Diabetol. 2019;18(1):68.
Iso T, Takahashi K, Yazaki K, et al. In-depth insight into the mechanisms of cardiac dysfunction in patients with type 1 diabetes mellitus using layer-specific strain analysis. Circ J. 2019;83(6):1330-1337.
Zhen Z, Chen Y, Liu JH, et al. Increased T-wave alternans is associated with subclinical myocardial structural and functional abnormalities in patients with type 2 diabetes. J Cardiol. 2016;68(4):329-334.
Obaid N, El Hadidy S, El Badry M, et al. The outcome of diabetic patients with cardiomyopathy in critical care unit: hospital and short-term outcome in a period of six months to one year. Open Access Maced J Med Sci. 2019;7(17):2796-2801.
Wang Y, Yang H, Huynh Q, et al. Diagnosis of nonischemic stage B heart failure in type 2 diabetes mellitus: optimal parameters for prediction of heart failure. JACC Cardiovasc Imaging. 2018;11(10):1390-1400.
Jensen MT, Risum N, Rossing P, et al. Self-reported dyspnea is associated with impaired global longitudinal strain in ambulatory type 1 diabetes patients with normal ejection fraction and without known heart disease - The Thousand & 1 Study. A. J Diabetes Complications. 2016;30:928-934.
Bjornstad P, Truong U, Pyle L, et al. Youth with type 1 diabetes have worse strain and less pronounced sex differences in early echocardiographic markers of diabetic cardiomyopathy compared to their normoglycemic peers: A RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) Study. J Diabetes Complications. 2016;30:1103-1110.
Van Berendoncks AM, Van Gaal L, De Block C, et al. Abnormal longitudinal peak systolic strain in asymptomatic patients with type i diabetes mellitus. Echocardiography. 2019;36(3):478-485.
Chen Q, Gan Y, Li Z-Y. Left ventricular diastolic dysfunction in type 2 diabetes patients: a novel 2D strain analysis based on cardiac magnetic resonance imaging. Comput Methods Biomech Biomed Engin. 2016;19:1330-1338.
Jeong E, Chung J, Liu H, et al. Role of mitochondrial oxidative stress in glucose tolerance, insulin resistance, and cardiac diastolic dysfunction. J Am Heart Assoc. 2016;5(5):e003046.
Htike ZZ, Yates T, Brady EM, et al. Rationale and design of the randomised controlled trial to assess the impact of liraglutide on cardiac function and structure in young adults with type 2 diabetes (the LYDIA study). Cardiovasc Diabetol. 2016;15:1-9.
Georgievska-Ismail L, Zafirovska P, Hristovski Z. Evaluation of the role of left atrial strain using two-dimensional speckle tracking echocardiography in patients with diabetes mellitus and heart failure with preserved left ventricular ejection fraction. Diabetes Vasc Dis Res. 2016;13:384-394.
Ernande L, Bergerot C, Rietzschel ER, et al. Diastolic dysfunction in patients with type 2 diabetes mellitus: Is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr. 2011;24:1268-1275.
Levelt E, Pavlides M, Banerjee R, et al. Ectopic and visceral fat deposition in lean and obese patients with type 2 diabetes. J Am Coll Cardiol. 2016;68:53-63.
Armstrong AC, Ambale-Venkatesh B, Turkbey E, et al. Association of cardiovascular risk factors and myocardial fibrosis with early cardiac dysfunction in type 1 diabetes: the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2017;40:405-411.
Mochizuki Y, Tanaka H, Matsumoto K, et al. Impaired mechanics of left ventriculo-atrial coupling in patients with diabetic nephropathy. Circ J. 2016;80:1957-1964.
Vukomanovic V, Suzic-Lazic J, Celic V, et al. Is There association between left atrial function and functional capacity in patients with uncomplicated type 2 diabetes? Int J Cardiovasc Imaging. 2020;36(1):15-22.
Cameli M, Mandoli GE, Lisi E, et al. Left atrial, ventricular and atrio-ventricular strain in patients with subclinical heart dysfunction. Int J Cardiovasc Imaging. 2019;35(2):249-258.
Mohseni-Badalabadi R, Mehrabi-Pari S, Hosseinsabet A. Evaluation of the left atrial function by two-dimensional speckle-tracking echocardiography in diabetic patients with obesity. Int J Cardiovasc Imaging. 2020;36(4):643-652.
Ahmed TA, Ahmed YA, Arafa AI, et al. Detection of occult right ventricular dysfunction in young Egyptians with type 1 diabetes mellitus by two-dimensional speckle tracking echocardiography. Indian Heart J. 2018;70(5):665-671.
Hodzic A, Ribault V, Maragnes P, et al. Decreased regional left ventricular myocardial strain in type 1 diabetic children: a first sign of diabetic cardiomyopathy? J Transl Intern Med. 2016;4:81-87.
Karagodin I, Aba-Omer O, Sparapani R, et al. Aortic stiffening precedes onset of heart failure with preserved ejection fraction in patients with asymptomatic diastolic dysfunction. BMC Cardiovasc Disord. 2017;17:1-10.
Nouhravesh N, Andersen HU, Jensen JS, et al. Retinopathy is associated with impaired myocardial function assessed by advanced echocardiography in type 1 diabetes patients - The Thousand & 1 Study. Diabetes Res Clin Pract. 2016;116:263-269.
Huang J, Hu HL, Yan ZN, et al. Peak systolic longitudinal rotation: a new tool for detecting left ventricular systolic function in patients with type 2 diabetes mellitus by two-dimensional speckle tracking echocardiography. BMC Cardiovasc Disord. 2019;19(1):137.
Vasanji Z, Sigal RJ, Eves ND, et al. Increased left ventricular extracellular volume and enhanced twist function in type 1 diabetic individuals. J Appl Physiol. 2017;123:394-401.
Cao Y, Zeng W, Cui Y, et al. Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain. Cardiovasc Diabetol. 2018;17:1-12.
Shang Y, Zhang X, Leng W, et al. Increased fractal dimension of left ventricular trabeculations is associated with subclinical diastolic dysfunction in patients with type-2 diabetes mellitus. Int J Cardiovasc Imaging. 2019;35(4):665-673.
Jensen MT, Fung K, Aung N, et al. Changes in cardiac morphology and function in individuals with diabetes mellitus: the UK biobank cardiovascular magnetic resonance substudy. Circ Cardiovasc Imaging. 2019;12(9):e009476.
Paiman EHM, van Eyk HJ, Bizino MB, et al. Phenotyping diabetic cardiomyopathy in Europeans and South Asians. Cardiovasc Diabetol. 2019;18(1):133.
Liu X, Yang ZG, Gao Y, et al. Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study. Cardiovasc Diabetol. 2018;17(1):139.
Zhu T, Zeng W, Chen Y, et al. 2D/3D CMR tissue tracking versus CMR tagging in the assessment of spontaneous T2DM rhesus monkeys with isolated diastolic dysfunction. BMC Med Imaging. 2018;18:47.
Shao G, Cao Y, Cui Y, et al. Early detection of left atrial and bi-ventricular myocardial strain abnormalities by MRI feature tracking in normotensive or hypertensive T2DM patients with preserved LV function. BMC Cardiovasc Disord. 2020;20:196.
Zhang Y, Zeng W, Chen W, et al. MR extracellular volume mapping and non-contrast T1ρ mapping allow early detection of myocardial fibrosis in diabetic monkeys. Eur Radiol. 2019;29(6):3006-3016.
Tadic M, Cuspidi C, Calicchio F, et al. Diabetic cardiomyopathy: How can cardiac magnetic resonance help? Acta Diabetol. 2020;57(9):1027-1034.
Gao Y, Ren Y, Guo YK, et al. Metabolic syndrome and myocardium steatosis in subclinical type 2 diabetes mellitus: A 1 H-magnetic resonance spectroscopy study. Cardiovasc Diabetol. 2020;19(1):70.
Leung M, Xie M, Durmush E, et al. Weight loss with sleeve gastrectomy in obese type 2 diabetes mellitus: impact on cardiac function. Obes Surg. 2016;26:321-326.
Leung M, Wong VW, Durmush E, et al. Cardiac dysfunction in type II diabetes: a bittersweet, weighty problem, or both? Acta Diabetol. 2017;54:91-100.
Lin J-L, Sung K-T, Su, C-H, et al. Cardiac structural remodeling, longitudinal systolic strain, and torsional mechanics in lean and nonlean dysglycemic chinese adults. Comparative Study. 2018;1:e007047.
Albu A, Para I. Left ventricular diastolic dysfunction in diabetes mellitus and the therapeutic role of exercise training. Balneo Research Journal. 2019;10(2):145-152.
Chang W-T, Cheng J-T, Chen Z-C. Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench. Cardiovasc Diabetol. 2016;15:113.
Iwakura K. Heart failure in patients with Type 2 diabetes mellitus: assessment with echocardiography and effects of antihyperglycemic treatments. J Echocardiogr. 2019;17(4):177-186.
Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14.
Doherty JU, Kort S, Mehran R, et al. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2019;73(4):488-516.
Badano LP, Kolias TJ, Muraru D, et al. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2018;19(6):591-600.
Collier P, Phelan D, Klein A. A test in context: myocardial strain measured by speckle-tracking echocardiography. J Am Coll Cardiol. 2017;69(8):1043-1056.
Pastore MC, De Carli G, Mandoli GE, et al. The prognostic role of speckle tracking echocardiography in clinical practice: evidence and reference values from the literature. Heart Fail Rev. 2020. [Epub ahead of print].
Tanaka H. Future perspectives for management of stage a heart failure. J Atheroscler Thromb. 2018;25(7):557-565.
Zegkos T, Parcharidou D, Ntelios D, et al. The prognostic implications of two-dimensional speckle tracking echocardiography in hypertrophic cardiomyopathy: current and future perspectives. Cardiol Rev. 2018;26(3):130-136.
Rimbaş RC, Dulgheru RI, Vinereanu D. Methodological gaps in left atrial function assessment by 2d speckle tracking echocardiography. Arq Bras Cardiol. 2015;105(6):625-636.
Li Y, Wan X, Xiao Q, et al. Value of 3D versus 2D speckle-tracking echocardiography for rv strain measurement: validation with cardiac magnetic resonance. JACC Cardiovasc Imaging. 2020;13(9):2056-2058.
Pryds K, Larsen AH, Hansen SM, et al. Myocardial strain assessed by feature tracking cardiac magnetic resonance in patients with a variety of cardiovascular diseases - A comparison with echocardiography. Sci Rep. 2019;9:11296.
Yuman L, Wan X, Xiao Q, et al. Value of 3D Versus 2D Speckle-Tracking Echocardiography for RV Strain Measurement: Validation With Cardiac Magnetic Resonance. JACC Cardiovasc Imaging. 2020;13(9):2056-2058.
Muraru D, Cucchini U, Mihăilă S, et al. Left ventricular myocardial strain by three-dimensional speckle-tracking echocardiography in healthy subjects: reference values and analysis of their physiologic and technical determinants. J Am Soc Echocardiogr. 2014;27(8):858-871.e1.